Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Sabatolimab in Combination with Hypomethylating Agents (HMAs) Was Safe in Patients (Pts) with Intermediate-, High-, or Very-High-Risk Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, Roger M. Lyons, Savita Nandal, Mushtaq Ashraf, Ramarao Thellaboina, Julie Ruckel-Kumar, Hans D. Menssen, Amer M. Zeidan

Blood (2023) 142 (Supplement 1): 4606.

https://doi.org/10.1182/blood-2023-186490

Published: 2023